GLS.NSE Glenmark Life Sciences Ltd.

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Glenmark Life Sciences Ltd. market cap is 104.23B.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Glenmark Life Sciences Ltd. 52 week high is 972.00 as of July 26, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Glenmark Life Sciences Ltd. 52 week low is 596.00 as of July 26, 2024.

Glenmark Life Sciences Ltd. stock price today is 854.00.

Glenmark Life Sciences Ltd. stock price yesterday was 887.00.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Glenmark Life Sciences Ltd.’s P/E ratio is 23.32.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Glenmark Life Sciences Ltd. P/B ratio is 4.3581.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Glenmark Life Sciences Ltd.'s EBITDA is 11.15.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Glenmark Life Sciences Ltd. 50-day moving average is 852.10.